Home Health Genome of 18-week-old foetus has been sequenced

Genome of 18-week-old foetus has been sequenced


US researchers have used a blood sample from mother and saliva from father to sequence the genome of a foetus in the womb.

At the time, the mother was just 18 weeks into the pregnancy.

The doctors said the findings, reported in Science Translational Medicine, could eventually lead to foetuses being screened for thousands of genetic disorders in a single and safe test.

However, they also caution it would raise “many ethical questions”.

US researchers have used a blood sample from mother and saliva from father to sequence the genome of a foetus in the womb

US researchers have used a blood sample from mother and saliva from father to sequence the genome of a foetus in the womb

The scientists at the University of Washington used pieces of the foetus’ DNA which naturally float around in the pregnant woman’s blood.


These fragments were then pieced together using the parents’ DNA as a guide to build a complete “map” of the foetus’s genome.

They then compared the genetic map drawn 18 weeks into pregnancy with the foetus’ actual DNA taken from the umbilical cord after birth. It was 98% accurate.

The researchers hope their findings will one day be used to test safely for genetic diseases.

Tests do already exist such as those for Down’s syndrome. To test for Down’s syndrome a sample is taken from the sac around the developing foetus, which comes with a risk of miscarriage.

They also say new genetic defects, which are not present in the parents, could be picked up if the technique could be improved. Such mutations form in the eggs, sperm or at conception.

There were 44 new mutations in the foetus and the screen at 18 weeks found 39 of them. However, the screening also detected 25 million possible new mutations or false positives.

One of the researchers, Dr. Jay Shendure, said: “This work opens up the possibility that we will be able to scan the whole genome of the foetus for more than 3,000 single-gene disorders through a single, non-invasive test.”